Skip to content

Kozhnosys developed by the CanScan prototype is being utilized in an observational study to collect and analyze volatile markers in the exhaled breath of cancer (GI, Cervical, Colorectal, head and neck) patients.

An observational study to collect and analyze volatile markers in the exhaled breath of cancer (GI, Cervical, Colorectal, head, and neck) patients using the CanScan prototype developed by Kozhnosys. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063799
Enrollment
20
Registered
2024-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R978- Other abnormal tumor markers

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Kozhnosys Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria for GI, Cervical, Colorectal, head, and neck Cancer 1. Willing to fill out the informed consent form 2. Female in the age group 20 to 80 years Women with newly diagnosed cancer (GI, Cervical, Colorectal, head, and neck) with/without common medical conditions like Hypertension, Hyperlipidaemia, Hypothyroidism, Arthritis, Asthma, GERD, Diabetes, PCOD, Vitamin deficiencies, etc. -20 evaluable subjects (4 patients each with above-mentioned cancer) 3. Confirmed cases of GI, Cervical, Colorectal, head, and neck cancer but not exposed to any previous treatment cycle/surgery. 4. Cases confirmed through endoscopy, PAP smear, Colonoscopy, MRI/CT, Ultrasonography or blood tests.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for GI, Cervical, Colorectal, head, and neck cancer 1. The age group is below 20 years. 2. Any known illness within 2 weeks from breath collection. 3. Already undergoing cancer treatment. 4. Undergone surgery for cancer tumor removal. 5. Undergoing chemo/radiation therapy for cancer treatment. 6. Positive, but no GI, Cervical, Colorectal, head, and neck cancer on the later investigation (Positive Sonography but negative biopsy report).

Design outcomes

Primary

MeasureTime frame
VOC (Volatile organic compounds) profile in GI, colorectal, cervical, Head & neck cancers.Timepoint: 4 weeks

Secondary

MeasureTime frame
Detection of volatile markers of biomarkers in GI, Colorectal, Cervical, Head, and Neck cancers using Canscan prototype. Timepoint: 4 weeks

Countries

India

Contacts

Public ContactJilma Peruvanagt

Kozhnosys. Pvt. Ltd

jilma@kozhnosys.com9833482033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026